Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet's disease.
Kluger
Nicolas
N
Poirier
Philippe
P
Guilpain
Philippe
P
Baixench
Marie-Thérèse
MT
Cohen
Pascal
P
Paugam
André
A
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications* / Q000188:drug therapy; D003455:Cryptococcus neoformans / Q000302:isolation & purification*; D006801:Humans; D000069285:Infliximab; D008297:Male; D016919:Meningitis, Cryptococcal / Q000209:etiology* / Q000382:microbiology; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D000069285:Infliximab; D009173:Mycophenolic Acid